Cuffless Blood Pressure Monitor Market Size, Share, Report 2023-2032
The global cuffless blood pressure monitor market size was estimated at around USD 0.61 billion in 2022 and it is projected to hit around USD 1.72 billion by 2032, growing at a CAGR of 10.92% from 2023 to 2032. The cuffless blood pressure monitor market in the United States was accounted for USD 193.3 million in 2022.
Key Pointers
Report Scope of the Cuffless Blood Pressure Monitor Market
| Report Coverage | Details |
| Revenue Share of North America in 2022 | 39% |
| Revenue Forecast by 2032 | USD 1.72 billion |
| Growth Rate from 2023 to 2032 | CAGR of 10.92% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Companies Covered | Omron; CardiacSense; Valencell, Inc.; SOMNOmedics GmbH; Blumio; Aktiia; Equate Health; Fourth Frontier Technologies LLC; A&D Medical; Biobeat Technologies; Healthstats International Pte. Ltd.; Biospectal; Huawei Device Co., Ltd.; LiveMetric; CHARMCARE |
The rising prevalence of hypertension and other cardiovascular diseases, coupled with the growing demand for non-invasive and continuous blood pressure monitoring, is expected to drive the market growth for cuffless blood pressure monitors. As per the WHO, high blood pressure is the leading cause of cardiovascular disorders such as strokes and heart disease, which cause 17.9 million deaths each year.
The COVID-19 pandemic has created a surge in demand for remote patient monitoring and telemedicine services. This has led to an increased interest in cuffless blood pressure monitoring devices, which can provide continuous and non-invasive monitoring of blood pressure levels without the need for a traditional blood pressure cuff.This shift towards home care devices has been driven by lockdowns in many countries and a preference for home-based healthcare settings.
As a result, major players in the market, such as Omron Healthcare, Inc., have been introducing various cuffless BP monitoring devices to cater to the needs of home care patients. For instance, in January 2021, Aktiia SA launched a 24/7 cuffless automated blood pressure monitoring system that provides continuous monitoring, even during sleep.
The market for cuffless blood pressure monitoring devices is expected to grow substantially due to the rising popularity of wearable fitness trackers. These devices, such as smartwatches, fitness bands, and activity trackers, allow individuals to monitor their blood pressure, physical activity, sleep patterns, and other health metrics. According to a survey conducted by ValuePenguin in March 2022, 45% of Americans wear smartwatches regularly.
Additionally, these devices were found to be most popular with Gen Z-ers (70%), millennials (57%), and women (51%). To keep up with the demand for innovative fitness trackers, market players are investing in developing devices that monitor blood pressure and other health metrics. For instance, in February 2023, Fitbit filed a patent application with the US Patent and Trademark Office for an in-built blood pressure sensor in its smartwatches.
The usage of cuffless BP monitors is anticipated to increase significantly in the coming years because of their convenience, accuracy, and self-monitoring abilities. These monitors are expected to become more in demand in the coming years due to the increasing prevalence of heart diseases and the importance of self-monitoring blood pressure.
According to a jointly published article in 2021 by the American Heart Association and American Medical Association, self-measured BP monitoring was found to be highly effective in diagnosing hypertension and controlling blood pressure. As a result, cuffless BP monitors are expected to gain popularity as a tool for managing hypertension and monitoring blood pressure at home, with significant implications for overall health outcomes.
Technological advancements and an increase in the frequency of product launches by key market players are expected to contribute to the growth of the market. For instance, in January 2023, Valencell showcased its Cuffless Blood Pressure Monitoring device for over-the-counter use, which allows users to accurately measure their blood pressure from their fingers without a cuff or calibration.This significant update to the portfolio is expected to provide an accurate and easy way for users and medical professionals to manage hypertension.
Type Insights
The wrist-based segment held the dominant share of 81% of the cuffless blood pressure monitor market in 2022. Wrist-based BP monitors utilize sensors and algorithms to measure blood pressure and other vital signs through the wrist. This technology has become increasingly accurate, reliable, and affordable, which has led to a significant increase in demand for these devices. The ability to track physical activity and blood pressure in real time has made wrist-based BP monitors a popular choice among fitness enthusiasts, athletes, and people with hypertension.
Furthermore, the increasing adoption of smartwatches and fitness trackers has been one of the driving factors behind the growth of wrist-based BP monitors. These devices offer a range of features, including heart rate monitoring, sleep tracking, and physical activity monitoring. For instance, OMRON Healthcare, Inc.'s HeartGuide is a clinically accurate wearable blood pressure monitor that also tracks fitness and sleep patterns.
End-use Insights
Based on end-use, the cuffless blood pressure monitor market has been further categorized into hospitals, home healthcare, diagnostics center, and other healthcare facilities. The hospital segment held a substantial revenue share of 25% of the market due to the increasing prevalence of hypertension, the convenience and accuracy of cuffless BP monitors, and the growing trend of adopting remote patient monitoring. These factors are significantly contributing to the adoption of these devices in hospitals.
The homecare segment is anticipated to witness the highest CAGR of 11.43% over the forecast period, owing to the cost-efficiency and mobility offered by cuffless BP monitors as an alternative to traditional monitoring methods. Majority of the key manufacturers are targeting the population that is looking to self-monitor its blood pressure from the convenience of their homes and is looking for devices that are effective, efficient, and economical. The fact that majority of the physicians are encouraging patients to keep a check on their cardiovascular health is expected to boost market growth.
Regional Insights
North America is anticipated to maintain its dominance in the market for cuffless BP monitors, with the region holding a 39% revenue share in 2022, due to the increasing prevalence of hypertension or high blood pressure in the region. According to the American Heart Association, nearly half of the adults aged 20 years and above in the U.S. have high blood pressure, which is a major risk factor for heart disease, strokes, and other health problems.
Furthermore, the increasing adoption of wearable health technology and growing awareness regarding the advantages of self-monitoring blood pressure are factors expected to contribute to the market growth over the forecast period. Moreover, the presence of major players in the region, such as Omron Healthcare, Valencell, Inc., Biobeat, and others fuels the growth of the market for cuffless BP monitors.
On the other hand, Asia Pacific is estimated to grow at the fastest rate during the forecast period, due to the increasing investment in healthcare infrastructure in recent years, particularly in emerging economies such as China and India. This investment has led to the development of advanced healthcare facilities and a growing demand for innovative medical devices and technologies, including cuffless BP monitors.
Cuffless Blood Pressure Monitor Market Segmentations:
By Type
By End-use
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cuffless Blood Pressure Monitor Market
5.1. COVID-19 Landscape: Cuffless Blood Pressure Monitor Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cuffless Blood Pressure Monitor Market, By Type
8.1. Cuffless Blood Pressure Monitor Market, by Type, 2023-2032
8.1.1. Wrist-based
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Finger-based Monitors
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Armband-based Monitors
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Cuffless Blood Pressure Monitor Market, By End-use
9.1. Cuffless Blood Pressure Monitor Market, by End-use, 2023-2032
9.1.1. Home Healthcare Settings
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Diagnostics Center
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Other Healthcare Facilities
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Cuffless Blood Pressure Monitor Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2020-2032)
10.1.2. Market Revenue and Forecast, by End-use (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.1.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.1.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.5.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.6.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.5.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.6.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.5.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.6.2. Market Revenue and Forecast, by End-use (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2020-2032)
10.5.2. Market Revenue and Forecast, by End-use (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.5.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.5.4.2. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 11. Company Profiles
11.1. Omron
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. CardiacSense
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Valencell, Inc
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. SOMNOmedics GmbH
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Blumio
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Aktiia
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Equate Health
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Fourth Frontier Technologies LLC
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. A&D Medical
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Biobeat Technologies
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers